Stereotactic ablative radiotherapy for hepatocellular carcinoma: History, current status, and opportunities

Liver Transpl. 2018 Mar;24(3):420-427. doi: 10.1002/lt.24991. Epub 2018 Feb 9.

Abstract

A variety of surgical and other local-regional approaches to the management of hepatocellular carcinoma (HCC) are in clinical use. External beam radiation therapy is a relative newcomer to the portfolio of treatment options. Advances in planning and delivery of radiation therapy, developing in parallel with and inspiring changing paradigms of tumor management in the field of radiation oncology, have led to growing interest in radiation therapy as a viable treatment option for HCC as well as other liver tumors. In this review, we discuss these advances, current trends in liver radiotherapy, as well as avenues of future clinical and basic research. Liver Transplantation 24 420-427 2018 AASLD.

Publication types

  • Historical Article
  • Review

MeSH terms

  • Animals
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / radiotherapy*
  • Diffusion of Innovation
  • Forecasting
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Liver Neoplasms / mortality
  • Liver Neoplasms / pathology
  • Liver Neoplasms / radiotherapy*
  • Patient Selection
  • Radiosurgery / adverse effects
  • Radiosurgery / history
  • Radiosurgery / trends
  • Risk Factors
  • Treatment Outcome